CRIBEA Project: Lesions Detected in Six Spanish Colorectal Cancer Screening Population Based Programmes

被引:0
作者
Portillo Villares, Isabel [1 ]
Arana-Arri, Eunate [2 ]
Idigoras Rubio, Isabel [1 ]
Espinas Pinol, Josep Alfons [3 ]
Perez Riquelme, Francisco [4 ]
de la Vega Prieto, Mariola [5 ]
Gonzalez Aledo, Alvaro [6 ]
Oceja Setien, Elena [6 ]
Vanaclocha Espi, Mercedes [7 ]
Ibanez Cabanell, Josefa [7 ]
Salas Trejo, Dolores [7 ]
机构
[1] Osakidetza Serv Vasco Salud, Programa Cribado Canc Colorrectal Pais Vasco, Bilbao, Spain
[2] Inst Invest BioCruces, Bilbao, Spain
[3] Serv Catalan Salud, Inst Catalan Oncol, Barcelona, Spain
[4] Serv Murciano Salud, Programas Asistenciales, Murcia, Spain
[5] Serv Canario Salud, Santa Cruz De Tenerife, Spain
[6] Serv Salud Cantabria, Santander, Spain
[7] Salud Publ Fdn Promoc Salud & Invest FISABIO Salu, Consejeria Salud, Valencia, Spain
来源
REVISTA ESPANOLA DE SALUD PUBLICA | 2017年 / 91卷
关键词
Cancer screening; Colorectal cancer; Adenoma; Early detection of cancer; Cancer screening test; National health Programs; FECAL IMMUNOCHEMICAL TESTS; OCCULT BLOOD-TESTS; MORTALITY; IMPACT; SEX; AGE;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Is this study, the results of six Colorectal Cancer Screening Population Programme are shown (Catalonia, Valence, Murcia, Cantabria, the Basque Country and the Canary Islands collected between 2005 and 2012. Thee programme use the New; occult blood let (FOBt) biennial. Objective: To determine and compare the results of lesions detected by the programmes. participation. sex. age and test used. Methods: Retrospective whom study based on people invited, aged between 50-74 years, in at least a complete round. lesions considered: Advanced Adenomas (AA), Colorectal Invasive Cancer (CRC) and both of them, known as Advanced Neoplasia (AN). Logistic Regression and time trends are used. Results: 1,995,719 of invitations registered, with an average participation-rate of 46.7%. 21,228 Advanced Neoplasias (2,813 CRC and 18,415 AA). Differences in detection rates observed between programmes (varying from 15.1 parts per thousand. to 35.8 parts per thousand between participants). Participation rates were related to lesions' detection rates (OR 1.25 in 40-60% of participation). Inmunochemical qualitative test showed an OR of 4.79 and quantitative test on OR of 7.30 over the guaiac test. Men showed an OR of 2.73 with respect to women. In 2012 the Advanced Neoplasia rate for women and men was 33.1 and 14.2 by 1,000 participants. Conclusions: The test used was the most important factor for detecting lesions. Time trends showed an increase in detected lesions caused by the change of the type of test in 2010.
引用
收藏
页数:10
相关论文
共 28 条
  • [1] [Anonymous], EST CANC INC MORT PR
  • [2] Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial
    Atkin, Wendy S.
    Edwards, Rob
    Kralj-Hans, Ines
    Wooldrage, Kate
    Hart, Andrew R.
    Northover, John M. A.
    Parkin, D. Max
    Wardle, Jane
    Duffy, Stephen W.
    Cuzick, Jack
    [J]. LANCET, 2010, 375 (9726) : 1624 - 1633
  • [3] Use of a faecal immunochemical test narrows current gaps in uptake for sex, age and deprivation in a bowel cancer screening programme
    Digby, Jayne
    McDonald, Paula J.
    Strachan, Judith A.
    Libby, Gillian
    Steele, Robert J. C.
    Fraser, Callum G.
    [J]. JOURNAL OF MEDICAL SCREENING, 2013, 20 (02) : 80 - 85
  • [4] Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study
    Faivre, J
    Dancourt, V
    Lejeune, C
    Tazi, MA
    Lamour, J
    Gerard, D
    Dassonville, F
    Bonithon-Kopp, C
    [J]. GASTROENTEROLOGY, 2004, 126 (07) : 1674 - 1680
  • [5] A standard for Faecal Immunochemical TesTs for Haemoglobin Evaluation Reporting (FITTER)
    Fraser, Callum G.
    Allison, James E.
    Young, Graeme P.
    Halloran, Stephen P.
    Seaman, Helen
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2014, 51 (02) : 301 - 302
  • [6] Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population
    Guittet, L.
    Bouvier, V.
    Mariotte, N.
    Vallee, J. P.
    Arsene, D.
    Boutreux, S.
    Tichet, J.
    Launoy, G.
    [J]. GUT, 2007, 56 (02) : 210 - 214
  • [7] Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
    Hardcastle, JD
    Chamberlain, JO
    Robinson, MHE
    Moss, SM
    Amar, SS
    Balfour, TW
    James, PD
    Mangham, CM
    [J]. LANCET, 1996, 348 (9040) : 1472 - 1477
  • [8] Meta-analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test
    Hassan, C.
    Rossi, P. Giorgi
    Camilloni, L.
    Rex, D. K.
    Jimenez-Cendales, B.
    Ferroni, E.
    Borgia, P.
    Zullo, A.
    Guasticchi, G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (10) : 929 - 940
  • [9] Kapidzic A., 2015, Clinical Gastroenterology and Hepatology
  • [10] Randomised study of screening for colorectal cancer with faecal-occult-blood test
    Kronborg, O
    Fenger, C
    Olsen, J
    Jorgensen, OD
    Sondergaard, O
    [J]. LANCET, 1996, 348 (9040) : 1467 - 1471